ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 14741 | Rec_0014765 | Anisaxin-4 |
GWLSKTWKKLENSAKKRIAEGIAIAIRGGPR |
Anisakis pegreffii [Animal] |
Antimicrobial |
Escherichia coli ATCC strain(s); clinical isolate(s) |
0.5-2 μM | MIC |
- | - |
YES |
| 14742 | Rec_0014766 | Myoinhibitory peptide 9 |
SNLSAAW |
Acerentomon sp [Animal] |
Neuropeptide |
- |
- | - |
16381860 | - |
NO |
| 14743 | Rec_0014767 | Beta-defensin |
AYGGRRRCWNNSGHCKKKCAADEVATAVCKNRQSCCV |
Bos mutus [Animal] |
Antibiotic, Antimicrobial, Defensin, Non-hemolytic, Non-ribosomal |
- |
- | - |
22751099 | - |
NO |
| 14744 | Rec_0014768 | Fallaxidin 3.2 |
GLLDFAKHVIGIASKL |
Litoria fallax [Animal] |
Antimicrobial |
- |
- | - |
- | - |
NO |
| 14745 | Rec_0014769 | Bactericidal permeability-increasing protein (BPI) |
PDLTGHEKFGLGNVKYNISRIHVTAVELPSASISLLPGSGIKLVIGNASLTIDMNWNIRTWMFKDSGRGTVHISKVFVTAIFSTPLDNTGPTTISLTSCRTTSGDIDIKLNGKS |
Pteruthius melanotis [Animal] |
Antibiotic, Antimicrobial, Anti-Gram-negative, Cytotoxin |
Gram-negative bacteria |
- | - |
- | - |
NO |
| 14746 | Rec_0014770 | Unnamed |
YVE |
Turban shell [Animal]; Animalia [Animal] |
Antihypertensive |
- |
- | - |
- | - |
NO |
| 14747 | Rec_0014771 | CAP18 [I20N] |
GLRKRLRKFRNKIKEKLKKNGQKIQGLLPKLAPRTDY |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Lactococcus lactis IL1403 |
- | - |
30245684;29852015 | - |
NO |
| 14748 | Rec_0014772 | Octyl Tridecaptin A1 [G3A] |
VXASWSXXFEVXA |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Escherichia coli ATCC 25922 |
3.13 μg/mL | MIC |
24816483 | - |
YES |
| 14749 | Rec_0014773 | Peptidoglycan hydrolase |
MKFNLSVFLFFFLITSCGSKKIIYNQPEKKFSKKIEKNKSIDSKKSNFLDTNTQMKVYVLQYSDLAIKEMNKFGIPASIKLAQALLESQAGKGELAQKSNNHFGIKCHKGWKGSSVSHDDDAKGECFRKYKKVEMSFRDHSEFLRYRNRYSELFRFKKNDYAKWAHGLKKAGYATDPKYAFKLISLIERFELWRFDGSKKPLEKSKIKSEGMYIVKKGDTLYSISRKFGKTIEFLKKLNNLKNNMLAVGQEIKLQ |
Flavobacteriales bacterium [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Non-hemolytic, Non-ribosomal |
- |
- | - |
- | - |
NO |
| 14750 | Rec_0014774 | Prepromelittin-RA1 |
RIGSILGALASKLPTLISWIKNR |
Odorrana andersonii [Animal] |
Antimicrobial, Antibacterial |
- |
- | - |
22029824 | - |
NO |
| 14751 | Rec_0014775 | Endolysin (EC 4.2.2.n2) (Lysis protein) (Lysozyme) (Transglycosylase) |
MKLDKNVQRKAFLDMIAYSEGTDNGRQPTKDRGYDVIVGGKLFSDYSKHPGVYVKLNAKLTSSAAGRYQVLEKFAKHYMKQLGLPDFGPASQDKIALQLIRECKALADIDEGRIHEAIRKCRSRWASLPGAGYGQHEQKIEKLIEVFKKAGGIVLD |
Escherichia phage APECc02 [Virus] |
Antimicrobial, Bacteriolytic enzyme, Ligase, Lyase, Cytolytic, Non-hemolytic |
- |
- | - |
27280590 | - |
NO |
| 14752 | Rec_0014776 | [D-P L-P]cGm (Derived from Gm) |
GCRRLCYKQRCVTYCRGPPR |
synthetic construct [Synthetic] |
Antimicrobial,Antibacterial,Anti-Gram-positive,Anti-Gram-negative,Antifungal,Anticancer,Cytotoxic |
K-562 |
14 | CC50 |
28741926 | - |
YES |
| 14753 | Rec_0014777 | LL-37 |
LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRITES |
Homo sapiens [Animal] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative |
Edwardsiella tarda I3 |
250 μg/mL | MIC |
33742508 | - |
YES |
| 14754 | Rec_0014778 | Peptide 5 |
FCYWXXXTKKRPKPFQWFWLXKKLMYPTYLKKFQWAVXHL |
synthetic construct [Synthetic] |
Anticancer |
MOLT-4 |
10 μM | Inhibition |
17559067 | - |
YES |
| 14755 | Rec_0014779 | MtDef5A |
KLCQKRSTTWSGPCLNTGNCKRQCINVEHATFGACHRQGFGFACFCYKKC |
Medicago truncatula [Plant] |
Antimicrobial, Antibacterial, Antifungal, Anti-Gram-positive |
Clavibacter michiganensis |
>12 μM | MIC |
29867843 | - |
YES |
| 14756 | Rec_0014780 | Unnamed |
TKVIP |
not reported [other] |
Antihypertensive |
Spontaneously hypertensive rat (SHR) |
9.2 mmHg | SBP decrease |
21185549 | - |
YES |
| 14757 | Rec_0014781 | HBD2 |
DPVTCLKSGAICHPVFCPRRYKQIGTCGLPGTKCCKP |
Homo sapiens [Animal] |
Antiviral, Entry inhibitor |
BK virus (Virus entry); Vero |
45 % | Flow cytometry |
18782756 | - |
YES |
| 14758 | Rec_0014782 | Peptidoglycan hydrolase |
MKKESMSRIERRKAQQRKKTPVQWKKSTTLFSSALIVSSVGTPVALLPVTAEATEEQPTNAEVAQAPTTETGLVETPTTETTPGTTEQPTTDSSTTTESTTESSKETPTTPSTEQPTVDSTTPVESGTTDSSVAEIAPVAPSTTESEAAPAVTPDDEVKVPEARVASAQTFSALSPTQSPSEFIAELARCAQPIAQANDLYASVMMAQAIVESGWGASTLSKAPNYNLFGIKGSYNGQSVYMDTWEYLNGKWLVKKEPFRKYPSYMESFQDNAHVLKTTSFQAGVYYYAGAWKSNTSSYRDATAWLTGRYATDPSYNAKLNNVIAAYNLTQYDTPSSGGNTGGGTVNPGTGGSNNQSGTNTYYTVKSGDTLNKIAAQYGVSVANLRSWNGISGDLIFVGQKLIVKKGASGNTGGSNNGGSNNNQSGTNTYYTVKSGDTLNKIAAQYGVSVANLRSWNGISGDLIFVGQKLIVKKGASGNTGGSNNGGSNNNQSGTNTYYTIKSGDTLNKIAAQYGVSVANLRSWNGISGDLIFAGQKIIVKKGNSGNTGGSSNGGSNNNQSGTNTYYTIKSGDTLNKISAQFGVSVANLQAWNNISGSLIFAGQKIIVKKGANSGSTNTNKPTNNGGGATTSYTIKSGDTLNKISAQFGVSVANLRSWNGIKGDLIFAGQTIIVKKGASAGGNASSTNSASGKRHTVKSGDSLWGLSMQYGISIQKIKQLNGLSGDTIYIGQTLKVG |
Enterococcus faecalis ATCC 29200 [Bacterium] |
Antimicrobial, Bacteriolytic enzyme, Glycosidase, Hydrolase |
- |
- | - |
- | - |
NO |
| 14759 | Rec_0014783 | MBD-4 (11-40)(P9) |
NGAICWGPCPTAFRQIGNCGHFKVRCCKIR |
synthetic construct [Synthetic] |
Antimicrobial, Anti-SARS-CoV-2 |
SARS-CoV-2:Inhibition of infection in Vero E6 cells |
2.4 μg/mL | IC50 |
26911565;32843628 | - |
YES |
| 14760 | Rec_0014784 | MreB(19) |
MLKKFRGMF |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Candida albicans ATCC 18804 |
15 μM | MLC (2 h complete killing; CFU assay) |
28230084 | - |
YES |